What was the most frequently reported adverse reaction to Lumigan 0.1 mg/ml (bimatoprost) in its 12-month clinical study?

The most frequently reported adverse reaction to Lumigan 0.1 mg/ml (bimatoprost) in its 12-month study was conjunctival hyperaemia (eye redness), occurring in 29% of patients and mostly trace to mild and non-inflammatory.